Lovima 75 microgram film-coated tablets (Desogestrel): Public Consultation
A 3-week consultation on a proposal to make Lovima 75 microgram film-coated tablets (Desogestrel) available from pharmacies.
Opened
12 Feb 2021
Closed
5 Mar 2021
↓
Linked documents
- Open Consultation Lovima public consultation document
- Other Data Protection and Privacy Information
- Analysis Lovima public assessment report
- Consultation Outcome A public consultation on reclassifying two medicines containing desogestrel from prescription only (POM) to pharmacy (P)
▤ Verbatim text from source document
We want to know what you think
- Lovima 75 microgram film-coated tablets are an oral contraceptive used to prevent pregnancy in women of childbearing age
- Lovima 75 microgram film-coated tablets are currently licensed as a prescription only medicine.
- We propose to make it available in pharmacies
- Medicines containing desogestrel will still be available on prescription from GPs and sexual health clinics
- Women will have choice in where they obtain supply of this medicine from, either on prescription or from pharmacies and may opt to switch between methods of supply
- We consider that this product may be available as a Pharmacy (P) medicine
- The Commission on Human Medicines has advised that this product can be available as a Pharmacy (P) medicine
- We want to know what you think about this change
Please tell us your views – please use the form below.
The deadline for comments is Friday 5 March 2021.
Other consultations
We are currently carrying out a public consultation on Hana, another desogestrel contraceptive product